Search alternatives:
point decrease » point increase (Expand Search)
ppm decrease » _ decrease (Expand Search), nn decrease (Expand Search), pa decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 21,221 - 21,240 results of 125,024 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((mean decrease) OR (point decrease)) ))', query time: 1.63s Refine Results
  1. 21221
    <i>Plasmodium</i> infectivity at day-time vs night time.

    <i>Plasmodium</i> infectivity at day-time vs night time. by Tibebu Habtewold (91734)

    Published 2022
    Save to List
    Saved in:
  2. 21222
    Silenced promoters exhibit increased H3K9me3 and decreased H3-acetylation and RNA Pol II recruitment.

    Silenced promoters exhibit increased H3K9me3 and decreased H3-acetylation and RNA Pol II recruitment. by Anna C. Groner (252216)

    Published 2010
    Save to List
    Saved in:
  3. 21223
    Figure S6 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S6 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes by Pauline J. van der Watt (15068109)

    Published 2023
    Save to List
    Saved in:
  4. 21224
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  5. 21225
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  6. 21226
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  7. 21227
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  8. 21228
    Figure S2 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes

    Figure S2 from Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes by Pauline J. van der Watt (15068109)

    Published 2023
    Save to List
    Saved in:
  9. 21229
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  10. 21230
    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  11. 21231
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  12. 21232
    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

    Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis by Shaina F. Bruce (15091273)

    Published 2023
    Save to List
    Saved in:
  13. 21233
    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance by Niklas Klümper (15048887)

    Published 2023
    Save to List
    Saved in:
  14. 21234
    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance

    Figure S1 from Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance by Niklas Klümper (15048887)

    Published 2023
    Save to List
    Saved in:
  15. 21235
    IGF1R was phosphorylated on hypoxic GRPs, and knockdown of IGF1 decreased the population of CD133- and Oct4-positive hypoxic GRPs.

    IGF1R was phosphorylated on hypoxic GRPs, and knockdown of IGF1 decreased the population of CD133- and Oct4-positive hypoxic GRPs. by Akiko Murakami (515972)

    Published 2014
    Save to List
    Saved in:
  16. 21236
    DURING THE CORONAVIRUS (COVID-19) PANDEMIC, DOES WEARING A MASK IMPROVE OR WORSEN PHYSICAL PERFORMANCE?

    DURING THE CORONAVIRUS (COVID-19) PANDEMIC, DOES WEARING A MASK IMPROVE OR WORSEN PHYSICAL PERFORMANCE? by Paulo Roberto Santos-Silva (2735518)

    Published 2021
    “…Secretory immunoglobulin A (IgA) is an antibody protein used by the immune system to neutralize pathogens, including viruses, and decreases with intense exercise. …”
    Save to List
    Saved in:
  17. 21237
    The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia

    The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia by Daniel Landau (440830)

    Published 2018
    “…Rats were sacrificed 4 weeks after CKD induction and 5 minutes after a single bolus of IV recombinant human EPO. …”
    Save to List
    Saved in:
  18. 21238
    Effect of 245 NA glycan on neuraminidase activity.

    Effect of 245 NA glycan on neuraminidase activity. by Harrison Powell (9040128)

    Published 2020
    Save to List
    Saved in:
  19. 21239
    Comparisons of group mean and standard deviation between control and ZIKV-Exposed subjects for the following measurements: Head circumference (HC), total intracranial volume (TICV), and the normalized volumes of cerebrospinal fluid (CSF), white matter (WM), cortical grey matter (GM), deep nuclear GM, hippocampus, amygdala, brainstem, and cerebellum.

    Comparisons of group mean and standard deviation between control and ZIKV-Exposed subjects for the following measurements: Head circumference (HC), total intracranial volume (TICV)... by Shanchita Ghosh (16705782)

    Published 2023
    Save to List
    Saved in:
  20. 21240
    Viscoelastic study of fresh and aged hot-mix asphalt with sintered calcined clay aggregate

    Viscoelastic study of fresh and aged hot-mix asphalt with sintered calcined clay aggregate by Juliano Rodrigues Spínola (10472730)

    Published 2021
    “…In the case of the asphalt binder, aging increases viscosity, associated to a decrease in the penetration and loss of its binding properties. …”
    Save to List
    Saved in:

Search Tools: